Alpha 2.0
Login Register
» Articles » PMID: 7165969

Pituitary Gigantism: a Disabling Condition

Overview
Journal Clin Endocrinol (Oxf)
Specialty Endocrinology
Date 1982 Sep 1
PMID 7165969
Citations 7
Authors
E M Whitehead
S M Shalet
D Davies
B A Enoch
D A Price
C G Beardwell
Affiliations
Soon will be listed here.
Citing Articles

Dyshomeostasis, obesity, addiction and chronic stress.

Marks D Health Psychol Open. 2017; 3(1):2055102916636907.

PMID: 28070396 PMC: 5193275. DOI: 10.1177/2055102916636907.

Combined treatment with octreotide LAR and pegvisomant in patients with pituitary gigantism: clinical evaluation and genetic screening.

Mangupli R, Rostomyan L, Castermans E, Caberg J, Camperos P, Krivoy J Pituitary. 2016; 19(5):507-14.

PMID: 27287035 DOI: 10.1007/s11102-016-0732-3.

Gigantism caused by growth hormone secreting pituitary adenoma.

Rhee N, Jeong K, Yang E, Kim C Ann Pediatr Endocrinol Metab. 2014; 19(2):96-9.

PMID: 25077093 PMC: 4114045. DOI: 10.6065/apem.2014.19.2.96.

Psychosocial morbidity in acromegaly: a study from India.

Mattoo S, Bhansali A, Gupta N, Grover S, Malhotra R Endocrine. 2008; 34(1-3):17-22.

PMID: 18953676 DOI: 10.1007/s12020-008-9112-8.

Dwarfism and gigantism in historical picture postcards.

Enderle A J R Soc Med. 1998; 91(5):273-8.

PMID: 9764085 PMC: 1296707. DOI: 10.1177/014107689809100511.